You Should Be Cautious Investing In Orexigen And Arena
moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboardSee who Orexigen is hiring next, click here to view […]
OREX
Arena Pharmarceuticals and Chelsea Therapeutics International Ltd Could Be Today’s Biggest Movers in Healthcare
moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboardSee who Orexigen is hiring next, click here to view […]
OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboardSee who Orexigen is hiring next, click here to view […]
PropThink: What Vivus’ and Arena’s Earnings Mean for Orexigen
[ACN Newswire] – By Jake KingOrexigen Therapeutics (NASDAQ:OREX) will be releasing its third quarter earnings report after the market’s close Wednesday night, and with all of the hoopla surrounding obesity drugs Qsymia … moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboard […]
PropThink: More Money, Same Problems; OREX Gains on Public Offering
[ACN Newswire] – By Jake KingWord from Orexigen Therapeutics (NASDAQ:OREX) Wednesday that it will be raising capital in the form of an equity offering came as little surprise to investors, and the market is taking the … moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboard […]
PropThink: FDA Interested in Accelerating Contrave’s Approval; Timeline Not Yet Clear
[ACN Newswire] – By Jake KingThe competition among obesity-drug makers continues to heat up Monday following an announcement from OrexigenTherapeutics (NASDAQ:OREX) that the company may be able to expedite the approval … moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboard […]
